INMUNE BIO INC. Cash Equivalents, at Carrying Value
INMUNE BIO INC. (INMB) had Cash Equivalents, at Carrying Value of $25.71 million as of 2024-03-31, per its 10-Q filed 2024-05-09.
Discontinued › Balance Sheet › Assets, Current › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2024-05-09
- 2024-03-31: Cash Equivalents, at Carrying Value $25.71M.
- 2023-12-31: Cash Equivalents, at Carrying Value $35.16M.
- 2023-09-30: Cash Equivalents, at Carrying Value $41.57M.
- 2023-06-30: Cash Equivalents, at Carrying Value $47.45M.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2024-03-31 | $25.71M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $35.16M 10-Q · filed 2024-05-09 |
| 2023-09-30 | $41.57M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $47.45M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $49.91M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $51.06M 10-K · filed 2024-03-28 |
| 2022-09-30 | $56.18M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $59.72M 10-Q · filed 2022-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |